International Parkinson and Movement Disorder Society®

“There are some striking differences, especially in the motor complications, which we didn't expect to find.” Discover what these sex-specific differences in PD mean for patient care.

New pilot program in Europe: Grow Together in Clinical-Science  Apply as a pair: 1 clinical resident + 1 basic science trainee. https://loom.ly/gYjnK-g

Digital health tech provides sensor-based means of measuring patient performance in various environments. Supportive AI can help extract meaningful information from the raw data. https://loom.ly/uEljnRM

Communicating a solid understanding of functional movement disorders to patient can be as challenging as making the correct diagnosis. https://loom.ly/KnUrZ0M

MRI-guided, high-intensity focused ultrasound (FUS) has advanced to become a complementary procedure for not only essential tremor but also Parkinson's disease. https://loom.ly/oQ5eBdk

Hear experts discuss recent advances in Huntington's disease, from its pathobiology and genetic mechanisms to investigational medications and neurosurgery. https://loom.ly/kRfjZak

Longitudinal analysis of MDS-UPDRS Part III subsets indicated each of the full scale's 33 items contributes meaningfully to prognostic sensitivity. Thus, #COA experts concluded that shortening the motor exam is not justifiable in early PD. https://loom.ly/c7TosIw

Apply for a 6-week Huntington's disease (HD) fellowship placement in Europe. Learn more: https://loom.ly/AIH8-Bg

Build a systematic approach to diagnosis, phenomenology, and evidence-based management. https://loom.ly/Q4Q0148

Frailty is more prevalent in older adults who have Parkinson's disease. Learn the myriad ways clinicans can define, measure and treat frailty to prevent falls and aid daily activities. https://loom.ly/X8CjvbA

While efficacious disease-modifying treatments for Parkinson's disease remain elusive, ongoing clinical trials are testing new  alpha-synuclein immunotherapies, stem cell transplants and multiple GLP-1 agonists. https://loom.ly/DCBvMQ8

Dr. Sabine Hilfiker addresses the slight differences of alpha-synuclein pathology in LRRK PD and what they could mean in terms of cell biology and molecular mechanisms. https://loom.ly/gvjcdnQ

Prof. Wassilios Meissner discusses scientific advances in multiple system atrophy,  from our growing understanding of MSA pathophysiology to potential diagnostic biomarkers to investigational therapeutics. https://loom.ly/VULSk1o

Dramatic increases in genetic testing globally over the last several years have enhanced our understanding of the genetic architecture of Parkinson's disease. https://loom.ly/uSuEfEQ

Dozens of autoantibodies describing new autoimmune movement disorders have been discovered, rapidly expanding the spectrum of recognized clinical phenotypes. https://loom.ly/fmgxu-k

Gratuit pour les membres de la MDS / Free for MDS members En français: https://loom.ly/SY-Bb4M In English: https://loom.ly/b11xOVY

MDS Young Member Group Research Highlight: Authors emphasize importance of routinely inspecting the tongue during a neurological examination, as abnormal movement is often missed. https://loom.ly/BfZLXoA

Learn how to find important clinical clues in symptoms your patients don't always think to share. https://loom.ly/jUYU8_w

The quest for PET tracers for imaging proteinopathies continues to progress and other updates from the Neuroimaging field. https://loom.ly/QdCEclY

A Conversation with the MDS President — an MDS Congress tradition. https://loom.ly/WSVOPSw

Gain funding, mentorship, and educational exchange to support a translational project. Trainees in Europe - Apply now: https://loom.ly/gYjnK-g

MDS Young Member Group Research Highlight: Paucity of non-White representation is stark in randomized controlled trials of investigational PD-modifying pharmacological therapies. https://loom.ly/oVMCVe0

Thank you for an incredible 2026 #MDSCongress. We hope to see you next year in Amsterdam, Netherlands September 26-30, 2027.

Thank you for an incredible 2026 #MDSCongress. See you next year in Amsterdam, Netherlands (September 26-30, 2027)!

“ I have been involved in over 1,000 DBS cases — but I had never seen anything like this before.” Dr. Genko Oyama gives us an inside look at the last full day of the #mdscongress — including 2 exciting scientific breakthroughs and his favorite case from the Video Challenge: https://loom.ly/oSStfgM

Congratulations to the winners of this year's #MDSCongress Video Challenge! Their interesting case was a unique challenge for the international experts. Gold: Malaysia, Joshua Ooi Silver: India, Arnab Adhya Bronze: Netherlands, Jeroen Kerstens

Congratulations to the winners of this year's #MDSCongress Video Challenge! Their interesting case was a unique challenge for the international experts. Gold - Malaysia, Joshua Ooi Silver - India, Arnab Adhya Bronze - Netherlands, Jeroen Kerstens

New #MDSCongress podcast: Join us for key takeaways from yesterday's sessions. https://loom.ly/e1zvYMk

Tohru Minamino presents about "Immuno-gerotherapeutics Targeting Senescent Cells for Age-associated Diseases" during his keynote at the #MDSCongress.

Thank you to the world-renown faculty who have shared their expertise at the 2026 #MDSCongress!

“That was an eye-opener for me." —Dr. Sanjay Pandey New #MDSCongress podcast: Discover the surprising takeaways from yesterday's presidential lectures and sessions. https://loom.ly/jmB4A2o

Tonight is #MDSCongress Networking Night! MDS young delegates, heath professionals, women in movement disorders, and basic scientists all had the opportunity to network and socialize with colleagues from across the globe.

New #MDSCongress podcast: Scientific highlights from the event so far. https://loom.ly/F4N8__4

Congratulations to Beomseok Jeon on receiving the Stanley Fahn Lecture Award at the #MDSCongress. He discussed "GCH-1 and Parkinson disease."

Congratulations to Vincenzo Bonifati on receiving the C. David Marsden Lecture Award at the #MDSCongress. He shared about "Paths to discovery and understanding: pedigrees, genes and movement disorders."

Congratulations to Junior Awardees Zixiao Yin and Richard Morton for their contributions to basic science and clinical research in the field of Movement Disorders. #MDSCongress

Kibra Kebede is recognized with the Public Service Award. Kibra is a disability rights advocate and founder of Ethiopia’s first Parkinson’s support organization, bringing clinical care, dignity, and economic stability to people with disabilities in underserved communities. #MDSCongress

Congratulations to Timothy Lynch and Irena Rektorova for receiving the President’s Distinguished Service Award at the #MDSCongress; this award is bestowed directly by the MDS President in recognition of their long and distinguished service to the Society and the field.

Congratulations to the newest MDS Honorary Members — individuals who have made extraordinary contributions to the Society: Michael Okun and A. Jon Stoessl! #MDSCongress

Congratulations to the 2026 MDS Presidential Honorary Member, Victor Fung!

Welcome from 2026 #MDSCongress in Seoul, Korea! This year, we are exploring "Understanding Aging in Movement Disorders."

Explore all 2,000+ novel research findings at #MDSCongress at mdsabstracts.org.

A person’s symptoms for multiple system atrophy (MSA) typically appear in a person’s 50s and can be categorized as Parkinsonian type or cerebellar type MSA.  

MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: Sumitomo Pharma Co., Ltd. (MARQUEE SPONSOR), uMed, uniQure, and Vima Therapeutics.

MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: neuroClues, Neuron23, Novartis Pharma AG, Parexel International, LLC, Rishena Medical Co., Ltd, Roche (MARQUEE SPONSOR), SAMSUNG PHARM. Co., LTD., and SK Biopharmaceuticals.

MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: Celestra Health Systems, Dasher Neuroscience Inc., Eisai Korea Inc., Empatica, Ferrer, FHC, Inc., Fulgent Genetics, GemVax&KAEL Co., Ltd., Indivi, IntraBio, Ipsen, JSC Vilimed, and NeuraLight.

MDS wishes to acknowledge the following Bronze Level supporters of the 2026 International Congress: Abbott, ActualSignal, Advanced Brain Monitoring, Inc., Amprion Inc., Arvinas Operations, Inc., Association of Movement Disorder Advanced Practice Providers, and AT&C Co., Ltd. #MDSCongress

MDS wishes to acknowledge the following Silver Level supporters of the 2026 International Congress: Abbott (MARQUEE SPONSOR), Teva Pharmaceuticals, Insightec (MARQUEE SPONSOR), Regeneron, STADA Specialty, Korea Tourism Organization, and Seoul Metropolitan Government. #MDSCongress

MDS wishes to acknowledge the following Gold Level supporters of the 2026 International Congress: Amneal Pharmaceuticals (MARQUEE SPONSOR), Boston Scientific, and Medtronic. #MDSCongress

MDS wishes to acknowledge the following Platinum Level supporters of the 2026 International Congress: AbbVie, H. Lundbeck A/S, Praxis Precision Medicines, and Supernus Pharmaceuticals. #MDSCongress